Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Dec
3
2019
After Decades of Broad Enforcement Discretion, FDA Signals New Approach to Homeopathic Drugs Epstein Becker & Green, P.C.
Jan
4
2016
FDA Releases Guidance to Assist Development of Advanced Technology to Modernize Pharmaceutical Manufacturing Epstein Becker & Green, P.C.
May
23
2016
Will Sad Facts Make Bad Law? Epstein Becker & Green, P.C.
Jun
2
2016
FDA Rule Providing Generic Manufacturers with the Ability to Unilaterally Update Safety Labels May be Abandoned Epstein Becker & Green, P.C.
Feb
7
2024
NJ Approves Cannabis Regulatory Amendment with Major Impacts on Class 5 Retail License Holders Epstein Becker & Green, P.C.
Nov
16
2016
Growing Acceptance Nationwide: More States Approve Marijuana Use Epstein Becker & Green, P.C.
Mar
26
2024
Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing Epstein Becker & Green, P.C.
Apr
11
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements Epstein Becker & Green, P.C.
Mar
9
2021
New Jersey’s Legalization of Recreational Marijuana Protects Employee Users While Still Prohibiting High Times at Work Epstein Becker & Green, P.C.
Jul
23
2018
The Ninth Circuit Concludes That the Terms of Taco Bell’s On-Premises Meal Periods Comply with California Meal Period Laws Epstein Becker & Green, P.C.
Aug
24
2018
DOJ Announces 11th Medicare Fraud Strike Force: The Newark/Philadelphia Regional Medicare Strike Force Epstein Becker & Green, P.C.
Nov
6
2018
The SUPPORT for Patients and Communities Act: Expanding Medicare Coverage of Telehealth Services to Combat the Opioid Crisis Epstein Becker & Green, P.C.
Mar
12
2015
Federal Trade Commission Focus on Privacy Epstein Becker & Green, P.C.
May
23
2023
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
Jan
8
2020
Employment Law This Week®: Recalibrating Federal Agencies, Marijuana Legalization, the Changing Nature of Work [Video] Epstein Becker & Green, P.C.
May
12
2020
New York Employers: Engage in the Interactive Process Before Disciplining Medical Marijuana Users Epstein Becker & Green, P.C.
May
6
2024
Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies? Epstein Becker & Green, P.C.
Mar
25
2021
Merger Reviews Likely to Address More Expansive—and Possibly New—Theories of Harm Epstein Becker & Green, P.C.
Feb
4
2022
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts Epstein Becker & Green, P.C.
Jun
1
2022
Unpacking Averages: Violations Found in Medical Device Warning Letters Epstein Becker & Green, P.C.
Jul
13
2022
FTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector Epstein Becker & Green, P.C.
Oct
13
2022
Four Years After Enactment – Clinical Laboratories Should Not Forget About EKRA Epstein Becker & Green, P.C.
Jun
1
2023
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study Epstein Becker & Green, P.C.
Jun
13
2023
An “Overbroad” Noncompete – the NLRB Has Found Its First Target Epstein Becker & Green, P.C.
Dec
30
2019
California Puts a Foot On the Scale to Drive Unionization Higher: AB 1291 Mandates State-Sponsored Assistance in Organizing Cannabis Employees Epstein Becker & Green, P.C.
Aug
1
2023
Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Sep
1
2023
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates Epstein Becker & Green, P.C.
Mar
19
2020
OCR Waives Penalties for Telehealth Communications During COVID-19 National Emergency Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins